Social Icons

Showing posts with label cancer. Show all posts
Showing posts with label cancer. Show all posts

Wednesday, May 1, 2013

Psychological Stress and Cancer

Psychological Stress and Cancer - National Cancer Institute Skip to content In English | En español National Cancer Institute at the National Institutes of Health National Cancer Instituteat the National Institutes of Health Questions About Cancer? 1-800-4-CANCER Search NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI Fact Sheet Reviewed: 12/10/2012 Search Fact Sheets by Keywordkeyword View Fact Sheets by TopicCancer TypeRisk Factors and Possible CausesPreventionDiet and NutritionDetection and DiagnosisCancer TherapySupport, Coping, and ResourcesTobacco and Smoking CessationInformation SourcesAbout NCICancer Health DisparitiesCancer Advances In Focus IndexEn españolPage OptionsPrint This PageEmail This DocumentBookmark & ShareRSS FeedPopular ResourcesNCI Dictionary of Cancer TermsNCI Drug DictionarySearch for Clinical TrialsNCI PublicationsEspañol Psychological Stress and CancerKey Points Psychological stress alone has not been found to cause cancer, but psychological stress that lasts a long time may affect a person’s overall health and ability to cope with cancer.People who are better able to cope with stress have a better quality of life while they are being treated for cancer, but they do not necessarily live longer.

What is psychological stress?

Psychological stress describes what people feel when they are under mental, physical, or emotional pressure. Although it is normal to experience some psychological stress from time to time, people who experience high levels of psychological stress or who experience it repeatedly over a long period of time may develop health problems (mental and/or physical).

Stress can be caused both by daily responsibilities and routine events, as well as by more unusual events, such as a trauma or illness in oneself or a close family member. When people feel that they are unable to manage or control changes caused by cancer or normal life activities, they are in distress. Distress has become increasingly recognized as a factor that can reduce the quality of life of cancer patients. There is even some evidence that extreme distress is associated with poorer clinical outcomes. Clinical guidelines are available to help doctors and nurses assess levels of distress and help patients manage it.

This fact sheet provides a general introduction to the stress that people may experience as they cope with cancer. More detailed information about specific psychological conditions related to stress can be found in the Related Resources and Selected References at the end of this fact sheet.

How does the body respond during stress?

The body responds to physical, mental, or emotional pressure by releasing stress hormones (such as epinephrine and norepinephrine) that increase blood pressure, speed heart rate, and raise blood sugar levels. These changes help a person act with greater strength and speed to escape a perceived threat.

Research has shown that people who experience intense and long-term (i.e., chronic) stress can have digestive problems, fertility problems, urinary problems, and a weakened immune system. People who experience chronic stress are also more prone to viral infections such as the flu or common cold and to have headaches, sleep trouble, depression, and anxiety.

Can psychological stress cause cancer?

Although stress can cause a number of physical health problems, the evidence that it can cause cancer is weak. Some studies have indicated a link between various psychological factors and an increased risk of developing cancer, but others have not.

Apparent links between psychological stress and cancer could arise in several ways. For example, people under stress may develop certain behaviors, such as smoking, overeating, or drinking alcohol, which increase a person’s risk for cancer. Or someone who has a relative with cancer may have a higher risk for cancer because of a shared inherited risk factor, not because of the stress induced by the family member’s diagnosis.

How does psychological stress affect people who have cancer?

People who have cancer may find the physical, emotional, and social effects of the disease to be stressful. Those who attempt to manage their stress with risky behaviors such as smoking or drinking alcohol or who become more sedentary may have a poorer quality of life after cancer treatment. In contrast, people who are able to use effective coping strategies to deal with stress, such as relaxation and stress management techniques, have been shown to have lower levels of depression, anxiety, and symptoms related to the cancer and its treatment. However, there is no evidence that successful management of psychological stress improves cancer survival.

Evidence from experimental studies does suggest that psychological stress can affect a tumor’s ability to grow and spread. For example, some studies have shown that when mice bearing human tumors were kept confined or isolated from other mice—conditions that increase stress—their tumors were more likely to grow and spread (metastasize). In one set of experiments, tumors transplanted into the mammary fat pads of mice had much higher rates of spread to the lungs and lymph nodes if the mice were chronically stressed than if the mice were not stressed. Studies in mice and in human cancer cells grown in the laboratory have found that the stress hormone norepinephrine, part of the body’s fight-or-flight response system, may promote angiogenesis and metastasis.

In another study, women with triple-negative breast cancer who had been treated with neoadjuvant chemotherapy were asked about their use of beta blockers, which are medications that interfere with certain stress hormones, before and during chemotherapy. Women who reported using beta blockers had a better chance of surviving their cancer treatment without a relapse than women who did not report beta blocker use. There was no difference between the groups, however, in terms of overall survival.

Although there is still no strong evidence that stress directly affects cancer outcomes, some data do suggest that patients can develop a sense of helplessness or hopelessness when stress becomes overwhelming. This response is associated with higher rates of death, although the mechanism for this outcome is unclear. It may be that people who feel helpless or hopeless do not seek treatment when they become ill, give up prematurely on or fail to adhere to potentially helpful therapy, engage in risky behaviors such as drug use, or do not maintain a healthy lifestyle, resulting in premature death.

How can people who have cancer learn to cope with psychological stress?

Emotional and social support can help patients learn to cope with psychological stress. Such support can reduce levels of depression, anxiety, and disease- and treatment-related symptoms among patients. Approaches can include the following:

Training in relaxation, meditation, or stress managementCounseling or talk therapyCancer education sessionsSocial support in a group settingMedications for depression or anxietyExercise

More information about how cancer patients can cope with stress can be found in the PDQ® summaries listed in the Related Resources section at the end of this fact sheet.

Some expert organizations recommend that all cancer patients be screened for distress early in the course of treatment. A number also recommend re-screening at critical points along the course of care. Health care providers can use a variety of screening tools, such as a distress scale or questionnaire, to gauge whether cancer patients need help managing their emotions or with other practical concerns. Patients who show moderate to severe distress are typically referred to appropriate resources, such as a clinical health psychologist, social worker, chaplain, or psychiatrist.

Selected References

Artherholt SB, Fann JR. Psychosocial care in cancer. Current Psychiatry Reports 2012;14(1):23-29.

[PubMed Abstract]

Fashoyin-Aje LA, Martinez KA, Dy SM. New patient-centered care standards from the Commission on Cancer: opportunities and challenges. Journal of Supportive Oncology 2012; e-pub ahead of print March 20, 2012.

[PubMed Abstract]

Lutgendorf SK, DeGeest K, Dahmoush L, et al. Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients. Brain, Behavior, and Immunity 2011;25(2):250-255.

[PubMed Abstract]

Lutgendorf SK, Sood AK, Anderson B, et al. Social support, psychological distress, and natural killer cell activity in ovarian cancer. Journal of Clinical Oncology 2005;23(28):7105-7113.

[PubMed Abstract]

Lutgendorf SK, Sood AK, Antoni MH. Host factors and cancer progression: biobehavioral signaling pathways and interventions. Journal of Clinical Oncology 2010;28(26):4094-4099.

[PubMed Abstract]

McDonald PG, Antoni MH, Lutgendorf SK, et al. A biobehavioral perspective of tumor biology. Discovery Medicine 2005;5(30):520-526.

[PubMed Abstract]

Melhem-Bertrandt A, Chavez-Macgregor M, Lei X, et al. Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. Journal of Clinical Oncology 2011;29(19):2645-2652.

[PubMed Abstract]

Moreno-Smith M, Lutgendorf SK, Sood AK. Impact of stress on cancer metastasis. Future Oncology 2010;6(12):1863-1881.

[PubMed Abstract]

Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychological Bulletin 2004;130(4):601-630.

[PubMed Abstract]

Sloan EK, Priceman SJ, Cox BF, et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Research 2010;70(18):7042-7052.

[PubMed Abstract]Related ResourcesAdjustment to Cancer: Anxiety and Distress (PDQ®)Depression (PDQ®)Family Caregivers in Cancer (PDQ®)Post-traumatic Stress Disorder (PDQ®)Facing Forward: Life After Cancer Treatment—Your FeelingsPain Control: Support for People with CancerNational Institute of Mental Health

This text may be reproduced or reused freely. Please credit the National Cancer Institute as the source. Any graphics may be owned by the artist or publisher who created them, and permission may be needed for their reuse.

We Can Answer Your Questions1-800-4-CANCERLiveHelp Online ChatNCI HomeContact UsPoliciesAccessibilityViewing FilesFOIASite HelpSite MapFollow Us: TwitterYouTubeFacebookRSSOther Versions: Mobile Mobile | Español

U.S. Department of Health and Human ServicesNational Institutes of HealthNational Cancer InstituteUSA.govNIH…Turning Discovery Into Health®
This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.

Friday, April 19, 2013

Dairy lowers breast cancer survival

Dairy products in the supermarket15/03/13

By James O'Brien

A new study shows women who eat and drink high-fat dairy products are less likely to survive breast cancer.

Patients who consumed products like milk, ice cream and cheese at least once a day were found to be 64% more likely to die from any cause than those who did not. The figure was 49% when it came to death from breast cancer.

The study followed the diets of 1,500 women with breast cancer over an average of 12 years. Participants were quizzed on how much dairy they had consumed in the previous 12 months, giving details on portion sizes and fat content.

All of the patients were told they had cancer around two years before the start of the study. A total of 372 died during the follow-up period, 189 from breast cancer, while 349 women had a recurrence of the cancer.

Scientists believe cow oestrogen could be behind higher breast cancer mortality in those who consume dairy products. The findings back up previous studies which uncovered a link between oestrogen and breast cancer.

Lead researcher Candyce Kroenke, from the Kaiser Permanente research institute in the US, said: "Women consuming larger amounts of high-fat dairy had higher breast cancer mortality as well as higher all-cause mortality and higher non-breast cancer mortality."

The research, published in the Journal of the National Cancer Institute, forms part of the Life After Cancer Epidemiology study which investigates how lifestyles affect breast cancer survival and occurrence.

Dr Susan Kutner, head of the Kaiser Permanente Northern California Regional Breast Care Task Force, has called for more emphasis on healthier diets in light of the findings.

"Women have been clamouring for this type of information. They're asking us, tell me what I should eat? With this information, we can be more specific about recommending low-fat dairy products," she said.


This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.

Wednesday, April 17, 2013

Spiritual Healing Improves Well-Being in Cancer Patients

The Journal of Pastoral Care published promising findings on a project that explored spirituality in medical practice and its role in the improvement of patient well-being and quality of life. According to the abstract published by the National Center for Biotechnology (NCBI), U.S. National Library of Medicine, the project:

Examined the feasibility of providing spiritual coaching with patients in an outpatient Radiation Oncology clinic setting. The purpose of spiritual coaching was to provide patients with opportunities to explore their current spiritual lives, increase their involvement in spiritually enhancing activities, and expand their spiritual opportunities. Quality-of-life measurements focused on feelings of hopefulness and distress were used in patients undergoing radiation treatment for cancer. This study suggests that there is a potential benefit for spiritual coaching in the care of cancer patients, and future studies will be done to further elucidate the relationship of spirituality and quality of life in this population.

The American Cancer Society (ACS) agrees that spiritual healing (also faith healing, spiritual coaching), has many benefits. According to the ACS, spiritual healing may promote peace of mind, reduce stress, relieve pain and anxiety, and strengthen to live. Activities may include praying with family members, friends, and/or a support group. It may also involve “touch” by a spiritual healer or group of healers, and it may even involve taking a pilgrimage to a religious shrine either locally or abroad.

When a person has a strong belief in a healer, prayer, or even a pilgrimage, a “placebo effect” can occur, which makes the person feel better. The placebo effect is an improvement that occurs because of a powerful belief in the treatment. The patient usually credits the improvement to the healer. Taking part in spiritual healing can “evoke the power of suggestion,” which promotes peace of mind. This can help people cope more effectively with their illness.

Further, the Mayo Clinic reports that several hundred studies have been conducted using spirituality and prayer. They have produced mixed results, some promising. According to the Mayo Clinic, there is a small body of evidence linking immune function to spiritual well-being. In addition, some studies of people with cancer report a change in the progression of the disease when prayer was used. Combining spirituality with other interventions improved the quality of life in some people with cancer. More research is still needed in this area, according to Mayo.

It is important to note a patient does not have to visit a healer to enjoy the benefits of spiritual healing. Positive, spiritual family members (and friends) can help by communicating with their loved one about feelings related to their faith in all areas from treatment to God. Family members can also pray with their loved one, pray for their loved one, and share this with them.


This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.

Friday, April 12, 2013

How To Find a Doctor or Treatment Facility If You Have Cancer

How To Find a Doctor or Treatment Facility If You Have Cancer - National Cancer Institute Skip to content In English | En español National Cancer Institute at the National Institutes of Health National Cancer Instituteat the National Institutes of Health Questions About Cancer? 1-800-4-CANCER Search NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI Fact Sheet In EnglishEn españolReviewed: 01/07/2013 Search Fact Sheets by Keywordkeyword View Fact Sheets by TopicCancer TypeRisk Factors and Possible CausesPreventionDiet and NutritionDetection and DiagnosisCancer TherapySupport, Coping, and ResourcesTobacco and Smoking CessationInformation SourcesAbout NCICancer Health DisparitiesCancer Advances In Focus IndexEn españolPage OptionsPrint This PageEmail This DocumentBookmark & ShareRSS FeedPopular ResourcesNCI Dictionary of Cancer TermsNCI Drug DictionarySearch for Clinical TrialsNCI PublicationsEspañol How To Find a Doctor or Treatment Facility If You Have CancerKey Points If you have been diagnosed with cancer, finding a doctor and treatment facility for your cancer care is an important step to getting the best treatment possible.Although the health care system is complex, resources are available to guide you in finding a doctor, getting a second opinion, and choosing a treatment facility.

How are doctors trained and certified to treat cancer patients?

When choosing a doctor for your cancer care, you may find it helpful to know some of the terms used to describe a doctor’s training and credentials. Most physicians who treat people with cancer are medical doctors (they have an M.D. degree) or osteopathic doctors (they have a D.O. degree). The basic training for both types of physicians includes 4 years of premedical education at a college or university, 4 years of medical school to earn an M.D. or D.O. degree, and postgraduate medical education through internships and residences. This training usually lasts 3 to 7 years. Physicians must pass an exam to become licensed (legally permitted) to practice medicine in their state. Each state or territory has its own procedures and general standards for licensing physicians.

Specialists are physicians who have completed their residency training in a specific area, such as internal medicine. Independent specialty boards certify physicians after they have fulfilled certain requirements. These requirements include meeting specific education and training criteria, being licensed to practice medicine, and passing an examination given by the specialty board. Doctors who have met all of the requirements are given the status of “Diplomate” and are board certified as specialists. Doctors who are board eligible have obtained the required education and training but have not completed the specialty board examination.

After being trained and certified as a specialist, a physician may choose to become a subspecialist. A subspecialist has at least 1 additional year of full-time education in a particular area of a specialty. This training is designed to increase the physician’s expertise in a specific field. Specialists can be board certified in their subspecialty as well.

The following are some specialties and subspecialties that pertain to cancer treatment:

Medical Oncology is a subspecialty of internal medicine. Doctors who specialize in internal medicine treat a wide range of medical problems. Medical oncologists treat cancer and manage the patient’s course of treatment. A medical oncologist may also consult with other physicians about the patient’s care or refer the patient to other specialists.Hematology is a subspecialty of internal medicine. Hematologists focus on diseases of the blood and related tissues, including the bone marrow, spleen, and lymph nodes.Radiation Oncology is a subspecialty of radiology. Radiology is the use of x-rays and other forms of radiation to diagnose and treat disease. Radiation oncologists specialize in the use of radiation to treat cancer.Surgery is a specialty that pertains to the treatment of disease by surgical operation. General surgeons perform operations on almost any area of the body. Physicians can also choose to specialize in a certain type of surgery; for example, thoracic surgeons are specialists who perform operations specifically in the chest area, including the lungs and the esophagus.

The American Board of Medical Specialties® (ABMS) is a not-for-profit organization that assists medical specialty boards with the development and use of standards for evaluation and certification of physicians. Information about other specialties that treat cancer is available from the ABMS website.

Almost all board-certified specialists are members of their medical specialty society. Physicians can attain Fellowship status in a specialty society, such as the American College of Surgeons (ACS), if they demonstrate outstanding achievement in their profession. Criteria for Fellowship status may include the number of years of membership in the specialty society, years practicing in the specialty, and professional recognition by peers.

How can I find a doctor who specializes in cancer care?

One way to find a doctor who specializes in cancer care is to ask for a referral from your primary care physician. You may know a specialist yourself, or through the experience of a family member, coworker, or friend.

The following resources may also be able to provide you with names of doctors who specialize in treating specific diseases or conditions. However, these resources may not have information about the quality of care that the doctors provide.

Your local hospital or its patient referral service may be able to provide you with a list of specialists who practice at that hospital.Your nearest NCI-designated cancer center can provide information about doctors who practice at that center. The NCI-Designated Cancer Centers Find a Cancer Center page provides contact information to help health care providers and cancer patients with referrals to NCI-designated cancer centers located throughout the United States.The ABMS has a list of doctors who have met certain education and training requirements and have passed specialty examinations. Is Your Doctor Board Certified lists doctors’ names along with their specialty and their educational background. Users must register to use this online self-serve resource, which allows users to conduct searches by a physician's name or area of certification and a state name. The directory is available in most libraries.The American Medical Association (AMA) DoctorFinder database provides basic information on licensed physicians in the United States. Users can search for physicians by name or by medical specialty.The American Society of Clinical Oncology (ASCO) provides an online list of doctors who are members of ASCO. The member database has the names and affiliations of nearly 30,000 oncologists worldwide. It can be searched by doctor’s name, institution, location, oncology specialty, and/or type of board certification.The American College of Surgeons (ACS) membership database is an online list of surgeons who are members of the ACS. The list can be searched by doctor’s name, geographic location, or medical specialty. The ACS can be contacted by telephone at 1–800–621–4111.The American Osteopathic Association (AOA) Find a Doctor database provides an online list of practicing osteopathic physicians who are AOA members. The information can be searched by doctor’s name, geographic location, or medical specialty. The AOA can be contacted by telephone at 1–800–621–1773.Local medical societies may maintain lists of doctors in each specialty.Public and medical libraries may have print directories of doctors’ names listed geographically by specialty.Your local Yellow Pages or Yellow Book may have doctors listed by specialty under “Physicians.”

If you are a member of a health insurance plan, your choice may be limited to doctors who participate in your plan. Your insurance company can provide you with a list of participating primary care doctors and specialists. It is important to ask whether the doctor you are considering is accepting new patients through your health plan. You also have the option of seeing a doctor outside your health plan and paying the costs yourself. If you have the option to change health insurance plans, you may first wish to consider which doctor or doctors you would like to use, and then choose a plan that includes your chosen physician(s).

If you are using a federal or state health insurance program such as Medicare or Medicaid, you may want to ask whether the doctor you are considering is accepting patients who use these programs.

You will have many factors to consider when choosing a doctor. To make an informed decision, you may wish to speak with several doctors before choosing one. When you meet with each doctor, you might want to consider the following:

Does the doctor have the education and training to meet my needs?Does the doctor use the hospital that I have chosen?Does the doctor listen to me and treat me with respect?Does the doctor explain things clearly and encourage me to ask questions?What are the doctor’s office hours?Who covers for the doctor when he or she is unavailable? Will that person have access to my medical records?How long does it take to get an appointment with the doctor?

If you are choosing a surgeon, you may wish to ask additional questions about the surgeon’s background and experience with specific procedures. These questions may include:

Is the surgeon board certified?Has the surgeon been evaluated by a national professional association of surgeons, such as the ACS?At which treatment facility or facilities does the surgeon practice?How often does the surgeon perform the type of surgery I need?How many of these procedures has the surgeon performed? What was the success rate?

It is important for you to feel comfortable with the specialist that you choose because you will be working closely with that person to make decisions about your cancer treatment. Trust your own observations and feelings when deciding on a doctor for your medical care.

How can I get another doctor’s opinion about the diagnosis and treatment plan?

After your doctor gives you advice about the diagnosis and treatment plan, you may want to get another doctor’s opinion before you begin treatment. This is known as getting a second opinion. You can do this by asking another specialist to review all of the materials related to your case. The doctor who gives the second opinion can confirm or suggest modifications to your doctor’s proposed treatment plan, provide reassurance that you have explored all of your options, and answer any questions you may have.

Getting a second opinion is done frequently, and most physicians welcome another doctor’s views. In fact, your doctor may be able to recommend a specialist for this consultation. However, some people find it uncomfortable to request a second opinion. When discussing this issue with your doctor, it may be helpful to express satisfaction with your doctor’s decision and care and to mention that you want your decision about treatment to be as thoroughly informed as possible. You may also wish to bring a family member along for support when asking for a second opinion. It is best to involve your doctor in the process of getting a second opinion, because your doctor will need to make your medical records (such as your test results and x-rays) available to the specialist who is giving the second opinion.

Some health care plans require a second opinion, particularly if a doctor recommends surgery. Other health care plans will pay for a second opinion if the patient requests it. If your plan does not cover a second opinion, you can still obtain one if you are willing to cover the cost.

If your doctor is unable to recommend a specialist for a second opinion, or if you prefer to choose one on your own, the following resources can help:

Many of the resources listed above for finding a doctor can also help you find a specialist for a consultation.The NIH Clinical Center in Bethesda, Maryland, is the research hospital for the NIH, including NCI. Several branches of the NCI provide second opinion services. The NCI fact sheet Cancer Clinical Trials at the NIH Clinical Center describes these NCI branches and their services.The R. A. Bloch Cancer Foundation, Inc., can refer cancer patients to institutions that are willing to provide multidisciplinary second opinions. A list of these institutions is available on the organization’s website. You can also contact the R. A. Bloch Cancer Foundation, Inc., by telephone at 816–854–5050 or 1–800–433–0464.

How can U.S. residents find treatment facilities?

Choosing a treatment facility is another important consideration for getting the best medical care possible. Although you may not be able to choose which hospital treats you in an emergency, you can choose a facility for scheduled and ongoing care. If you have already found a doctor for your cancer treatment, you may need to choose a facility based on where your doctor practices. Your doctor may be able to recommend a facility that provides quality care to meet your needs. You may wish to ask the following questions when considering a treatment facility:

Has the facility had experience and success in treating my condition?Has the facility been rated by state, consumer, or other groups for its quality of care?How does the facility check on and work to improve its quality of care?Has the facility been approved by a nationally recognized accrediting body, such as the ACS Commission on Cancer and/or The Joint Commission?Does the facility explain patients’ rights and responsibilities? Are copies of this information available to patients?Does the treatment facility offer support services, such as social workers and resources, to help me find financial assistance if I need it?Is the facility conveniently located?

If you are a member of a health insurance plan, your choice of treatment facilities may be limited to those that participate in your plan. Your insurance company can provide you with a list of approved facilities. Although the costs of cancer treatment can be very high, you do have the option of paying out-of-pocket if you want to use a treatment facility that is not covered by your insurance plan. If you are considering paying for treatment yourself, you may wish to discuss the possible costs with your doctor beforehand. You may also want to speak with the person who does the billing for the treatment facility. Nurses and social workers may also be able to provide you with more information about coverage, eligibility, and insurance issues.

The following resources may help you find a hospital or treatment facility for your care:

The NCI-Designated Cancer Centers Find a Cancer Center page provides contact information for NCI-designated cancer centers located throughout the country.The ACS’s Commission on Cancer (CoC) accredits cancer programs at hospitals and other treatment facilities. More than 1,430 programs in the United States have been designated by the CoC as Approved Cancer Programs. The ACS website offers a searchable database of these programs. The CoC can be contacted by telephone at 312–202–5085 or by e-mail at CoC@facs.org.The Joint Commission is an independent not-for-profit organization that evaluates and accredits health care organizations and programs in the United States. It also offers information for the general public about choosing a treatment facility. The Joint Commission can be contacted by telephone at 630–792–5000.The Joint Commission offers an online Quality Check® service that patients can use to determine whether a specific facility has been accredited by the Joint Commission and to view the organization’s performance reports.

How can people who live outside the United States find treatment facilities in or near their countries?

If you live outside the United States, facilities that offer cancer treatment may be located in or near your country. Cancer information services are available in many countries to provide information and answer questions about cancer; they may also be able to help you find a cancer treatment facility close to where you live. A list of these cancer information services is available on the website of the International Cancer Information Service Group, an independent international organization of cancer information services. A list may also be requested by writing to the NCI Public Inquiries Office at:

Cancer Information Service
Suite 300
6116 Executive Boulevard
Bethesda, MD 20892–8322
USA

The Union for International Cancer Control (UICC) is another resource for people living outside the United States who want to find a cancer treatment facility. The UICC consists of international cancer-related organizations devoted to the worldwide fight against cancer. UICC membership includes research facilities and treatment centers and, in some countries, ministries of health. Other members include volunteer cancer leagues, associations, and societies. These organizations serve as resources for the public and may have helpful information about cancer and treatment facilities. To find a resource in or near your country, contact the UICC at:

Union for International Cancer Control (UICC)
62 route de Frontenex
1207 Geneva
Switzerland
+ 41 22 809 1811
http://www.uicc.org
 

How can people who live outside the United States get a second opinion or have cancer treatment in the United States?

Some people living outside the United States may wish to obtain a second opinion or have their cancer treatment in this country. Many facilities in the United States offer these services to international cancer patients. These facilities may also provide support services, such as language interpretation, assistance with travel, and guidance in finding accommodations near the treatment facility for patients and their families.

If you live outside the United States and would like to obtain cancer treatment in this country, you should contact cancer treatment facilities directly to find out whether they have an international patient office. The NCI-Designated Cancer Centers Find a Cancer Center page offers contact information for NCI-designated cancer centers throughout the United States.

Citizens of other countries who are planning to travel to the United States for cancer treatment generally must first obtain a nonimmigrant visa for medical treatment from the U.S. Embassy or Consulate in their home country. Visa applicants must demonstrate that the purpose of their trip is to enter the United States for medical treatment; that they plan to remain for a specific, limited period; that they have funds to cover expenses in the United States; that they have a residence and social and economic ties outside the United States; and that they intend to return to their home country.

To determine the specific fees and documentation required for the nonimmigrant visa and to learn more about the application process, contact the U.S. Embassy or Consulate in your home country. A list of links to the websites of U.S. Embassies and Consulates worldwide can be found on the U.S. Department of State’s website.

More information about nonimmigrant visa services is available on the U.S. Department of State's Temporary Visitors to the U.S. page.

Related ResourcesCancer Clinical Trials at the NIH Clinical Center Find a Cancer CenterHow To Find Resources in Your Own Community If You Have CancerNational Organizations That Offer Cancer-Related Support Services

This text may be reproduced or reused freely. Please credit the National Cancer Institute as the source. Any graphics may be owned by the artist or publisher who created them, and permission may be needed for their reuse.

We Can Answer Your Questions1-800-4-CANCERLiveHelp Online ChatNCI HomeContact UsPoliciesAccessibilityViewing FilesFOIASite HelpSite MapFollow Us: TwitterYouTubeFacebookRSSOther Versions: Mobile Mobile | Español

U.S. Department of Health and Human ServicesNational Institutes of HealthNational Cancer InstituteUSA.govNIH…Turning Discovery Into Health®
This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.

Sunday, December 23, 2012

Genetic Gamble: Drugs aim to make different types of cancer self-destruction

Click Here! Great uncertainties remain, but such drugs could mean new treatments for rare cancers, neglected, as well as those municipalities. Merck, Roche and Sanofi are racing to develop their own versions of a drug they hope to restore a mechanism that normally makes it severely damaged the cells self-destruct and could potentially be used against half of all cancers.
--> No pharmaceutical company has ever conducted a clinical trial of a drug in patients who have many different types of cancer, researchers and federal regulators say. "This is a taste of the future in the development of cancer drugs," said Dr. Otis Brawley Webb, medical and Scientific Director of the American Cancer Society. "We expect the organ from which cancer will be less important in the future and the most important molecular target," he added.
And this has important implications for Philanthropy, cancer experts say. Support groups should move from fund-raising for cancers in particular to push for research aimed at many cancers at once, said Dr. Brawley. John Walter, chief executive officer of the leukemia and Lymphoma Society, agreed, saying that by pooling forces "our strength can be leveraged." At the heart of this search for new cancer drugs are patients like Joe Bellino, who was an employee of the post office until his cancer made him too ill to work. Seven years ago, he went to the hospital for a hernia surgery, only to learn that he had a rare cancer, liposarcoma of the adipose cells. A large tumor was wrapped around a wire that connects the testicle in the abdomen. "I was shocked," he said in an interview this summer.
Companies have long ignored liposarcoma, not seeing no market for drugs to treat a cancer that affects so few. But it's ideal for drug testing of Sanofi, because the tumors are almost always the exact genetic drugs problem was to attack — a merger of two large proteins. If the drug works, it should bring these tumors raging a setback. Then Sanofi would you test the drug on a wide range of cancers with a similar genetic alteration. But if the drug fails against liposarcoma, Sanofi grudgingly admit defeat. "For us, this is a go/no-go," said Laurent Debussche, a scientist from Sanofi leads drug company seeks.
The genetic alteration of drug targets has tantalized scientists for decades. Normal healthy cells have a mechanism that tells them to die if their DNA is damaged too badly for repair. Cancer cells grotesquely damaged DNA, so ordinarily you would self-destruct. A protein known as p53 that Dr. Gary Gilliland of Merck called Angel of death cell normally sets things in motion. But cancer cells deactivate p53, or directly with a mutation, or indirectly, by attaching the p53 protein to another cellular protein that blocks. The dream of cancer researchers has long been to revive p53 in cancer cells that die on their own. P53 's story began in earnest about 20 years ago. Excitement ran so high that, in 1993, Science magazine has anointed the molecule of the year and put him on the cover. An editorial gave the possibility of a cure for a dreaded killer in the not too distant future ".
Companies began hunting for a drug to restore p53 in cells where it has been disabled by mutations. But while scientists know how to block genes, they haven't figured out how to add or restore them. Researchers have tried gene therapy, adding good copies of the p53 gene in cancer cells. That did not work. Then, instead of going after the mutated p53 genes, they went after half the cancers that used the alternative route to disable p53 by blocking linking it to a known protein like MDM2. When they stick together the two proteins, the protein p53 doesn't work anymore. Maybe, the researchers thought they might find a wedge between the two myself proteins and raise their share.
The problem was that both proteins are enormous and cling tightly to each other. Drug molecules are generally very small. How could find one that would separate these two bruisers, like a referee in a boxing match? In 1996, researchers at Roche has noticed a small pocket between the colossi where a small molecule could slip and pry them apart. It took six years, but Roche found such a molecule and named Nutlin because the lab was in Nutley, NJ
But Nutlins didn't work as drugs because they were not absorbed into the body. Roche, Merck and Sanofi persevered, testing thousands of molecules.
At Sanofi, the stubborn avant-garde scientist, Dr. Debussche, maintained an obsession with p53 for two decades. Finally, in 2009, his team, along with Shaomeng Wang at the University of Michigan and a biotech company, Ascenta Therapeutics, found a promising compound. The company tested the drug every day pumping in the stomachs of mice with sarcoma.e

Saturday, December 22, 2012

As Chavez battles cancer, Maduro waits

AppId is over the quota
AppId is over the quota
Nicolas Maduro (shown in 2007) could take the reins if Hugo Chavez's health worsens.Nicolas Maduro (shown in 2007) could take the reins if Hugo Chavez's health worsens.NEW: Analyst: Nicolas Maduro was behind radical foreign policy decisions, but also compromisesHugo Chavez says he wants Maduro to replace him if his health worsensMaduro, 50, is Venezuela's vice president and foreign ministerHe started his career as a bus driver, then later become a union leader and a politician

(CNN) -- He began his career as a bus driver in Caracas, then rose through the ranks to become a member of Venezuelan President Hugo Chavez's inner circle.

Now, if Chavez's health worsens, Vice President Nicolas Maduro could be the one to take the reins.

Chavez, who is battling cancer, said Saturday that Maduro should replace him "if something were to happen that would incapacitate me."

"My firm opinion, as clear as the full moon -- irrevocable, absolute, total -- is ... that you elect Nicolas Maduro as president," Chavez said, waving a copy of the Venezuelan Constitution as he spoke. "I ask this of you from my heart. He is one of the young leaders with the greatest ability to continue, if I cannot."

The televised address marked the first time the Venezuelan president specified whom he wants to be his successor.

Maduro, 50, has long been a high-profile face in Chavez's administration. He is often seen in the front row of Chavez's press conferences and has traveled to Cuba as the Venezuelan leader undergoes cancer treatment.

Read more: Venezuelan lawmakers debate Chavez's trip to Cuba for cancer surgery

var currExpandable="expand18";if(typeof CNN.expandableMap==='object'){CNN.expandableMap.push(currExpandable);}var mObj={};mObj.type='video';mObj.contentId='';mObj.source='bestoftv/2012/12/09/nr-oppmann-hugo-chavez-illness.cnn';mObj.videoSource='CNN';mObj.videoSourceUrl='';mObj.lgImage="http://i2.cdn.turner.com/cnn/dam/assets/121209040549-nr-oppmann-hugo-chavez-illness-00003218-story-body.jpg";mObj.lgImageX=300;mObj.lgImageY=169;mObj.origImageX="214";mObj.origImageY="120";mObj.contentType='video';CNN.expElements.expand18Store=mObj;"He is without a doubt one the ministers who is closest to Chavez," political analyst German Campos told CNN en Espa?ol after Chavez tapped Maduro as vice president in October.

Maduro is also Venezuela's foreign minister, a position he's held since 2006.

In that role, Maduro has been the South American country's top diplomat as tensions rose with the United States and ties grew with Cuba.

"The U.S. Department of the Treasury is trying to become a sort of world police agency to describe decent citizens of our country ... as drug traffickers," Maduro said in 2011, after the department added four Venezuelan officials to its drug kingpin list.

"A country like that has no moral authority to judge generals and political officials in Venezuela," Maduro said. "We reject it and we believe that the drug trafficking mafias are there, in a sick society like the United States."

After security screeners detained him at New York's John F. Kennedy Airport in 2006, Maduro called the U.S. government "racist" and "Nazi" and said the United States does not appreciate Latin American countries.

There are two sides to Maduro, said Javier Corrales, a professor of political science at Amherst College in Massachusetts.

"On the one hand, he has been behind some of the most radical, crazy foreign policy decisions of the Chavez administration. Support for Libya, you name it, all the radical decisions, he has been behind them," Corrales said. "But he also has been behind some of the most pragmatic and conciliatory decisions, including the turnaround in relations with Colombia."

That's a marked contrast with the inflammatory Chavez, who rarely turns to compromise, Corrales said.

Before his role representing Venezuela abroad, Maduro honed his political skills at home.

He became a union leader while working for the Caracas metro system.

After Chavez came to power in 1999, Maduro participated in an assembly that drafted a new constitution.

He served as a congressman until 2006, when he was tapped as foreign minister.

If the president dies, Venezuela's constitution specifies that the vice president assumes the presidency until new elections can be held.

But analysts have said it's difficult to determine who would succeed Chavez, whose personal charisma and popularity have led to throngs of followers who call themselves "Chavistas."

"You have to ask what's held things together in Venezuela. ... Part of what's held it together is that Chavez, despite his government's problems, is somebody who has a tremendous emotional connection and charisma with a lot of Venezuelans," said Michael Shifter, president of the Washington-based Inter-American Dialogue think tank.

"All of the people who are potential successors of Chavez are people who are polarizing and confrontational," Shifter told CNN earlier this year. "They're loyal to Chavez, but they don't have Chavez's ability to connect with most Venezuelans."

Polls have indicated that although Chavez still has strong backing from his supporters, other possible successors don't seem to generate that kind of enthusiasm. A February poll by the Datanalisis firm showed Maduro with 9.8% support among militant members of Chavez's United Socialist Party of Venezuela.

But that was before Chavez's remarks supporting Maduro on Saturday, which will likely bolster support for the vice president within the government and among fervent Chavistas, Corrales said.

"When popular presidents make an endorsement, that always has an effect," Corrales said. "This is an important thing that Chavez needed to do."

When he named Maduro as vice president in October, Chavez noted his extensive experience on "different battlefronts."

"The bourgeoisie make fun of Nicolas Maduro because he was a bus driver," Chavez said, "and look where he's going now."

CNN's Patrick Oppmann, Mariano Castillo and Arthur Brice and journalist Osmary Hernandez contributed to this report.

ADVERTISEMENTDecember 18, 2012 -- Updated 1609 GMT (0009 HKT) Although there are many illegal weapons in Europe, why are there fewer shootings? A gunman opened fire in a Connecticut elementary school on December 14, killing 26 people -- 20 of them children.December 19, 2012 -- Updated 1045 GMT (1845 HKT) South Koreans are choosing their next leader -- and it's the economy rather than security concerns which may sway their vote.December 19, 2012 -- Updated 0320 GMT (1120 HKT) Last week, Beijing's leading English-language newspaper, China Daily, begun publishing a weekly Africa edition targeting Africa's growing middle class. December 18, 2012 -- Updated 1600 GMT (0000 HKT) UK ministers give Queen Elizabeth II place mats and a continent, sort of, as she attends her first cabinet meeting.December 18, 2012 -- Updated 1946 GMT (0346 HKT) How 10-year-old Romeo is taking Brand Beckham to the next generation.December 18, 2012 -- Updated 1433 GMT (2233 HKT) With 1 billion tourists in 2012, it's little wonder the last 12 months have drummed up some juicy fodder for aviation reporters.December 17, 2012 -- Updated 1516 GMT (2316 HKT) CNN's Arwa Damon reports from inside Aleppo on a female Syrian war photographer breaking taboos in the name of freedom. December 18, 2012 -- Updated 1121 GMT (1921 HKT) Mark Schwarzer, Luke Wiltshire and Matt McKay Why clamerbing into a vat of freezing water may not be the most efficient way to chill out after strenuous exercise.December 19, 2012 -- Updated 0848 GMT (1648 HKT) Forget old conspiracy theories about snake bites and fatal poisons. King Ramesses III died after a brutal throat slashing, a new study says. Gogobot users added 10 million travel postcards and stories to their Facebook feeds. Here's a rundown of the most-shared locations and attractions December 19, 2012 -- Updated 1042 GMT (1842 HKT) In the crowded world of social media, with its virtual currency of likes and followers, some people will do anything for attention.December 19, 2012 -- Updated 0144 GMT (0944 HKT) Apple's share price has fallen more than 25% since its record high set three months ago -- no less than five analysts have lowered their price targets. Malala or Merkel? Zuckerberg or Baumgartner? Tell us the famous face who mattered most to you during the last 12 months.Today's five most popular storiesMoreADVERTISEMENT

View the original article here

Thursday, August 9, 2012

Women with HIV may not have a high risk of cervical cancer: study

Monday, 23 July, HealthDay News)--Infection with HIV, the virus that causes AIDS--did not appear to increase the risk of cervical cancer, a new survey showed.

The researchers looked at more than 400 HIV infected women and nearly 300 HIV-free women, all of whom had normal Pap test and a negative result for tumors cause of human papillomavirus DNA in the beginning of the study. Know that some types of the human papilloma virus (HPV) causes cervical cancer.

After five years of follow-up, the risk of precancerous cervical diseases was similarly low for both groups of women. None of the women developed cancer of the cervix, Dr. Howard Strickler and colleagues at Albert Einstein College of medicine at Yeshiva University in New York said in a press release.

The study was scheduled to present a briefing Sunday at the International AIDS Conference in Washington, the District of Colombia and appears in the July 25 issue of the journal of the American Medical Association.

The results show that the five-year risk of cervical cancer in HIV-infected women who have normal Pap smear and HPV tumour without causing a risk similar to HIV-free women, researchers say.

"Current investigation underscores the potential for a new era of molecular testing--including HPV, as well as other biomarkers--to improve cervical cancer screening in HIV-infected women," in conclusion, the authors of the study.

--Robert Preidt MedicalNews Copyright © 2012 HealthDay. All rights reserved. Source: Journal of the American Medical Association, press release, July 22, 2012



View the original article here

Wednesday, August 8, 2012

Charity breast cancer increases the amount of liabilities the value of Mammograms: researchers

By Amanda Gardner
HealthDay Reporter

THURSDAY, Aug. 2 HealthDay News)--Breast Cancer Charity that brought the world the Pink Ribbon, which exaggerates benefits of Mammography by minimizing its harms, claim scientists.

Susan g. Komen organization is referred to for the Cure, as stated in the announcement, 2011 that the pointer of cancer survival five years during breast caught early 98%, while only 23% if not caught early.

"The survival Statistics posed are eye-catching and relevant. Means that the woman is crazy and irresponsible if not go to detect, "said Dr. Steve Woloshin, co-author article challenge charity. "But the statistics are misleading."

In accordance with the comment that Woloshin appears online Aug. 2 in the BMJ, in her 50s woman who refers to regular mammograms for 10 years will be the only cuts the chance of dying by a fraction of a percentage point--every 10 000 women who will not be able to screened 7 deaths.

The reason for the discrepancy?

Survival statistics, calculate how much a woman lives only after the diagnosis, the researchers explained.

If 100 women were diagnosed with breast cancer at the age of 67 after feeling the tumor and all died three years later, at the age of 70, the survival rate of five years will be 0 per cent.

But if cancers were detected by Mammography, when women were 64 and they still died at the age of 70, the survival of five years will be 100 percent.

Komen also minimizes the harms that may come from over-screening in accordance with article.

For every woman whose life is saved by Mammography, between two and 10 women are overdiagnosed, which means they are told they have cancer, if not and end up going through unnecessary treatment.

Up to half of the women who are inspected annually by the Decade they receive at least one false positive, which means must undergo biopsy and breast cancer have the experience of fear of thinking, if only temporarily.

The article falls at a time when there has been a growing furor over the value of breast cancer. The U.S. preventive services Task Force now recommends that women in their 40s not get regular mammograms.

American Cancer Society recommends that all women aged 40 and over get annual mammograms.

In the end, women must obtain reliable information from their doctors or other sources about the risks and benefits of Mammography. One problem is that not all primary care doctors know the numbers right to transfer their patients, according to the latest research.

Overall, few doctors would argue that there are certain advantages to Mammography.

Dr. Stephanie Bernik, head of Lenox Hill Hospital in New York City, Onkologiczna, supports push for a Cancer Charity.

"As doctors, we believe that breast cancer is extremely beneficial," she said. "Screening save lives, but probably is not as dramatic as sometimes took too."

Adds Woloshin, who is Professor of medicine and community and family medicine at Dartmouth School of Medicine and Institute of the Dartmouth health policy and clinical practice: "there is some benefit, but the size is of a different order than what is implied by the advertising. Women's decisions should be good for each other. "

Komen Foundation representative defended the position of the organization.

"Everyone Agrees that Mammography is not perfect, but it is the best tool for the detection of commonly available that we have today," said Chandini Portteus, Vice President of Komen research, evaluation and scientific programmes. "My wymówienie for years the science has to improve, therefore the Komen is putting millions of dollars for tests to detect breast cancer before symptoms through biomarkers," for example, she explained.

"Komen is also financing research to accurately predict a 6,000 cancer and which are not," still Portteus. "When we invest in obtaining those responses, we believe is simply irresponsible effectively discourage women from taking steps to know what happens to their health," she noted.

"These numbers are not in question," said Portteus. "Early detection allows for early treatment, which granted women the best chance of surviving breast cancer."

MedicalNewsCopyright © 2012 HealthDay. All rights reserved. SOURCE: Stephanie Bernik, M.D., Chief, surgical oncology, Lenox Hill Hospital, New York City, New York; Steven Woloshin, M.D., Professor of medicine and community and family medicine, Dartmouth School of Medicine and Institute of the Dartmouth health policy and clinical practice, Lebanon, Navy; Chandini Portteus, Vice-President, research, evaluation and scientific programmes, Susan g. Komen for the Cure; 2 Aug. 2012, BMJ, online



View the original article here

Saturday, July 7, 2012

Examples of medical marketing for the week: full body skin cancer scans, robotic hysterectomy

Both of these were sent to me by journalists:

An email pitch letter from a medical group:

Medical Office has First Full Body Scanner to Protect Against Skin Cancer

Dear xxxxx,

We thought that this might make for a very interesting and informative article. With the approach of summer break, this is a time when most people head outdoors. It’s important for people to remember to protect their families against one of the most common forms of cancer today: skin cancer. Current statistics show that 1 in 5 Americans will develop skin cancer in their lifetime.

—- uses the latest technology to detect and protect against skin cancer. They are the only practice in central (could be any state) to offer this system which creates a digital map of the entire body.

Now let’s look at the evidence:  The US Preventive Services Task Force states that “the current evidence is insufficient to assess the balance of benefits and harms of using a whole-body skin examination by a primary care clinician or patient skin self-examination for the early detection of cutaneous melanoma, basal cell cancer, or squamous cell skin cancer in the adult general population.”

The other example came from a journalist who wrote, “Doesn’t it seem particularly exploitative to use a 26-year-old woman’s hysterectomy for this?” The news release/pitch:

Surgeons at xxx Health Center have completed the first robot-assisted surgery in xxxx County.

The first patient was 26-year-old xxx, who underwent a robot-assisted hysterectomy April 13.

Hysterectomies and other gynecological procedures are the first of many robot-assisted surgical procedures that will be offered at xxx.

“We are proud to offer the most high-tech, minimally invasive treatment options available anywhere right here at xxx. Now our patients can benefit from the latest surgical technologies without leaving home,” says (the) president of xxx Health Center.

For advertising disguised as news, see this puff piece in the business section of The Tennessean online, “daVinci robot works miracles.” 

Addendum 5 hours later:  The Nashville Scene website reports, “Tennessean Farms Out Health Section to Hospital Flacks.“  And Paul Raeburn of the Knight Science Journalism Tracker writes:

“The changes come as the Tennessean institutes a paywall for many of its stories. (Newspaper management) said that because of the paywall, “The Tennessean will continue its mission of serving Middle Tennesseans for years to come.”

With regard to some things, maybe. But not with regard to health news. The paper has already failed in that mission.”

Finally, for absurdity in robot hype, see a Seattle doc’s You Tube video of how he used a robotic surgical system to fold a paper airplane – and see how the blogger known as The Skeptical Scalpel grounds that hype.


View the original article here

Examples of medical marketing for the week: full body skin cancer scans, robotic hysterectomy

Both of these were sent to me by journalists:

An email pitch letter from a medical group:

Medical Office has First Full Body Scanner to Protect Against Skin Cancer

Dear xxxxx,

We thought that this might make for a very interesting and informative article. With the approach of summer break, this is a time when most people head outdoors. It’s important for people to remember to protect their families against one of the most common forms of cancer today: skin cancer. Current statistics show that 1 in 5 Americans will develop skin cancer in their lifetime.

—- uses the latest technology to detect and protect against skin cancer. They are the only practice in central (could be any state) to offer this system which creates a digital map of the entire body.

Now let’s look at the evidence:  The US Preventive Services Task Force states that “the current evidence is insufficient to assess the balance of benefits and harms of using a whole-body skin examination by a primary care clinician or patient skin self-examination for the early detection of cutaneous melanoma, basal cell cancer, or squamous cell skin cancer in the adult general population.”

The other example came from a journalist who wrote, “Doesn’t it seem particularly exploitative to use a 26-year-old woman’s hysterectomy for this?” The news release/pitch:

Surgeons at xxx Health Center have completed the first robot-assisted surgery in xxxx County.

The first patient was 26-year-old xxx, who underwent a robot-assisted hysterectomy April 13.

Hysterectomies and other gynecological procedures are the first of many robot-assisted surgical procedures that will be offered at xxx.

“We are proud to offer the most high-tech, minimally invasive treatment options available anywhere right here at xxx. Now our patients can benefit from the latest surgical technologies without leaving home,” says (the) president of xxx Health Center.

For advertising disguised as news, see this puff piece in the business section of The Tennessean online, “daVinci robot works miracles.” 

Addendum 5 hours later:  The Nashville Scene website reports, “Tennessean Farms Out Health Section to Hospital Flacks.“  And Paul Raeburn of the Knight Science Journalism Tracker writes:

“The changes come as the Tennessean institutes a paywall for many of its stories. (Newspaper management) said that because of the paywall, “The Tennessean will continue its mission of serving Middle Tennesseans for years to come.”

With regard to some things, maybe. But not with regard to health news. The paper has already failed in that mission.”

Finally, for absurdity in robot hype, see a Seattle doc’s You Tube video of how he used a robotic surgical system to fold a paper airplane – and see how the blogger known as The Skeptical Scalpel grounds that hype.


View the original article here

Monday, July 2, 2012

Catch Cancer Early

AppId is over the quota
AppId is over the quota

April 6, 2012 / Vol. 61 / No. RR–2
Good Laboratory Practices for Biochemical Genetic Testing and Newborn Screening for Inherited Metabolic Disorders
CE Available

This report provides recommendations for good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders. The recommended practices address the benefits of using a quality management system approach, factors to consider before introducing new tests, establishment and verification of test performance specifications, the total laboratory testing process, confidentiality of patient information and test results, and personnel qualifications and responsibilities for laboratory testing for inherited metabolic diseases. These recommendations are intended for laboratories that perform biochemical genetic testing to improve the quality of laboratory services and for newborn screening laboratories to ensure the quality of laboratory practices for inherited metabolic disorders. These recommendations also are intended as a resource for medical and public health professionals who evaluate laboratory practices, for users of laboratory services to facilitate their collaboration with newborn screening systems and use of biochemical genetic tests, and for standard-setting organizations and professional societies in developing future laboratory quality standards and practice recommendations.


View the original article here

Monday, June 18, 2012

Catch Cancer Early

AppId is over the quota
AppId is over the quota

April 6, 2012 / Vol. 61 / No. RR–2
Good Laboratory Practices for Biochemical Genetic Testing and Newborn Screening for Inherited Metabolic Disorders
CE Available

This report provides recommendations for good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders. The recommended practices address the benefits of using a quality management system approach, factors to consider before introducing new tests, establishment and verification of test performance specifications, the total laboratory testing process, confidentiality of patient information and test results, and personnel qualifications and responsibilities for laboratory testing for inherited metabolic diseases. These recommendations are intended for laboratories that perform biochemical genetic testing to improve the quality of laboratory services and for newborn screening laboratories to ensure the quality of laboratory practices for inherited metabolic disorders. These recommendations also are intended as a resource for medical and public health professionals who evaluate laboratory practices, for users of laboratory services to facilitate their collaboration with newborn screening systems and use of biochemical genetic tests, and for standard-setting organizations and professional societies in developing future laboratory quality standards and practice recommendations.


View the original article here

Sunday, June 17, 2012

Timing is Everything with Breast Cancer

AppId is over the quota
AppId is over the quota

April 6, 2012 / Vol. 61 / No. RR–2
Good Laboratory Practices for Biochemical Genetic Testing and Newborn Screening for Inherited Metabolic Disorders
CE Available

This report provides recommendations for good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders. The recommended practices address the benefits of using a quality management system approach, factors to consider before introducing new tests, establishment and verification of test performance specifications, the total laboratory testing process, confidentiality of patient information and test results, and personnel qualifications and responsibilities for laboratory testing for inherited metabolic diseases. These recommendations are intended for laboratories that perform biochemical genetic testing to improve the quality of laboratory services and for newborn screening laboratories to ensure the quality of laboratory practices for inherited metabolic disorders. These recommendations also are intended as a resource for medical and public health professionals who evaluate laboratory practices, for users of laboratory services to facilitate their collaboration with newborn screening systems and use of biochemical genetic tests, and for standard-setting organizations and professional societies in developing future laboratory quality standards and practice recommendations.


View the original article here

Thursday, June 7, 2012

Timing is Everything with Breast Cancer
















Good Laboratory Practices for Biochemical Genetic Testing and Newborn Screening for Inherited Metabolic Disorders
CE Available
This report provides recommendations for good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders. The recommended practices address the benefits of using a quality management system approach, factors to consider before introducing new tests, establishment and verification of test performance specifications, the total laboratory testing process, confidentiality of patient information and test results, and personnel qualifications and responsibilities for laboratory testing for inherited metabolic diseases. These recommendations are intended for laboratories that perform biochemical genetic testing to improve the quality of laboratory services and for newborn screening laboratories to ensure the quality of laboratory practices for inherited metabolic disorders. These recommendations also are intended as a resource for medical and public health professionals who evaluate laboratory practices, for users of laboratory services to facilitate their collaboration with newborn screening systems and use of biochemical genetic tests, and for standard-setting organizations and professional societies in developing future laboratory quality standards and practice recommendations.

Timing is Everything with Breast Cancer
















Good Laboratory Practices for Biochemical Genetic Testing and Newborn Screening for Inherited Metabolic Disorders
CE Available
This report provides recommendations for good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders. The recommended practices address the benefits of using a quality management system approach, factors to consider before introducing new tests, establishment and verification of test performance specifications, the total laboratory testing process, confidentiality of patient information and test results, and personnel qualifications and responsibilities for laboratory testing for inherited metabolic diseases. These recommendations are intended for laboratories that perform biochemical genetic testing to improve the quality of laboratory services and for newborn screening laboratories to ensure the quality of laboratory practices for inherited metabolic disorders. These recommendations also are intended as a resource for medical and public health professionals who evaluate laboratory practices, for users of laboratory services to facilitate their collaboration with newborn screening systems and use of biochemical genetic tests, and for standard-setting organizations and professional societies in developing future laboratory quality standards and practice recommendations.

Timing is Everything with Breast Cancer
















Good Laboratory Practices for Biochemical Genetic Testing and Newborn Screening for Inherited Metabolic Disorders
CE Available
This report provides recommendations for good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders. The recommended practices address the benefits of using a quality management system approach, factors to consider before introducing new tests, establishment and verification of test performance specifications, the total laboratory testing process, confidentiality of patient information and test results, and personnel qualifications and responsibilities for laboratory testing for inherited metabolic diseases. These recommendations are intended for laboratories that perform biochemical genetic testing to improve the quality of laboratory services and for newborn screening laboratories to ensure the quality of laboratory practices for inherited metabolic disorders. These recommendations also are intended as a resource for medical and public health professionals who evaluate laboratory practices, for users of laboratory services to facilitate their collaboration with newborn screening systems and use of biochemical genetic tests, and for standard-setting organizations and professional societies in developing future laboratory quality standards and practice recommendations.

Timing is Everything with Breast Cancer


Good Laboratory Practices for Biochemical Genetic Testing and Newborn Screening for Inherited Metabolic Disorders
CE Available
This report provides recommendations for good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders. The recommended practices address the benefits of using a quality management system approach, factors to consider before introducing new tests, establishment and verification of test performance specifications, the total laboratory testing process, confidentiality of patient information and test results, and personnel qualifications and responsibilities for laboratory testing for inherited metabolic diseases. These recommendations are intended for laboratories that perform biochemical genetic testing to improve the quality of laboratory services and for newborn screening laboratories to ensure the quality of laboratory practices for inherited metabolic disorders. These recommendations also are intended as a resource for medical and public health professionals who evaluate laboratory practices, for users of laboratory services to facilitate their collaboration with newborn screening systems and use of biochemical genetic tests, and for standard-setting organizations and professional societies in developing future laboratory quality standards and practice recommendations.

Timing is Everything with Breast Cancer


Good Laboratory Practices for Biochemical Genetic Testing and Newborn Screening for Inherited Metabolic Disorders
CE Available
This report provides recommendations for good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders. The recommended practices address the benefits of using a quality management system approach, factors to consider before introducing new tests, establishment and verification of test performance specifications, the total laboratory testing process, confidentiality of patient information and test results, and personnel qualifications and responsibilities for laboratory testing for inherited metabolic diseases. These recommendations are intended for laboratories that perform biochemical genetic testing to improve the quality of laboratory services and for newborn screening laboratories to ensure the quality of laboratory practices for inherited metabolic disorders. These recommendations also are intended as a resource for medical and public health professionals who evaluate laboratory practices, for users of laboratory services to facilitate their collaboration with newborn screening systems and use of biochemical genetic tests, and for standard-setting organizations and professional societies in developing future laboratory quality standards and practice recommendations.

Timing is Everything with Breast Cancer


Good Laboratory Practices for Biochemical Genetic Testing and Newborn Screening for Inherited Metabolic Disorders
CE Available
This report provides recommendations for good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders. The recommended practices address the benefits of using a quality management system approach, factors to consider before introducing new tests, establishment and verification of test performance specifications, the total laboratory testing process, confidentiality of patient information and test results, and personnel qualifications and responsibilities for laboratory testing for inherited metabolic diseases. These recommendations are intended for laboratories that perform biochemical genetic testing to improve the quality of laboratory services and for newborn screening laboratories to ensure the quality of laboratory practices for inherited metabolic disorders. These recommendations also are intended as a resource for medical and public health professionals who evaluate laboratory practices, for users of laboratory services to facilitate their collaboration with newborn screening systems and use of biochemical genetic tests, and for standard-setting organizations and professional societies in developing future laboratory quality standards and practice recommendations.

Friday, May 11, 2012

Off to Beijing for National Cancer Institute workshop for Chinese journalists

photo by Jorge Lascar on Flickr

The website will be on hold over the next week, as I’m traveling to Beijing to help lead a workshop for Chinese journalists hosted by the National Cancer Institute and the Cancer Institute and Hospital, Chinese Academy of Medical Sciences.

This will be the third international journalism workshop I’ve done with the National Cancer Institute – with several more on the horizon within the next year.

We are gratified to see the global reach of efforts like ours – built on the pioneering work done by an Australian team that founded the first Media Doctor site two years before we got started.  Now, as the yellow stars on the map below show, such projects have sprung up around the world.  And the invitations for talks and workshops, like the upcoming one in Beijing, continue to come in.



View the original article here